Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1
- 1 March 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 29 (2-3) , 297-307
- https://doi.org/10.1016/0166-3542(95)00936-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after bindingAntiviral Research, 1996
- Synthesis and Structure-Activity Relationships of Phenylenebis(methylene)-Linked Bis-Tetraazamacrocycles That Inhibit HIV Replication. Effects of Macrocyclic Ring Size and Substituents on the Aromatic LinkerJournal of Medicinal Chemistry, 1995
- V3-Mediated Heparin Neutralization of HIV Type 1AIDS Research and Human Retroviruses, 1994
- Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100Antimicrobial Agents and Chemotherapy, 1994
- Crystal Structure of the Principal Neutralization Site of HIV-1Science, 1994
- Knocking-Out Concentrations of HIV-1-Specific Inhibitors Completely Suppress HIV-1 Infection and Prevent the Emergence of Drug-Resistant VirusVirology, 1993
- Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytesAIDS, 1991
- Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compoundsJournal of Virological Methods, 1988
- Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitroAntimicrobial Agents and Chemotherapy, 1987
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985